ArticleEndocrine connections2018
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS.
Dorte Glintborg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it